The Latest Cardiac and Vascular News
NEW YORK, Aug. 23, 2026 /PRNewswire/ — Pulnovo Medical, a globally recognized pioneer in medical devices for pulmonary hypertension (PH) and heart failure (HF), today announced the enrollment of the first two patients in its PULSE-LHD clinical trial, conducted under a U.S. Food and Drug…
WASHINGTON, Aug. 20, 2026 /PRNewswire/ — The Heart Failure Society of America (HFSA) announced the slate of 2026 HFSA Award recipients who will be recognized at the HFSA Annual Scientific Meeting 2026, October 9-12 in Phoenix, AZ. Our field advances because of the dedication,…
Heart Failure Society of America’s (HFSA) Annual Scientific Meeting (ASM) 2026 will convene the entire heart failure care team to explore late-breaking science, emerging technologies, device innovation, and practical strategies that can improve care for millions of patients living with…
BRENTWOOD, Tenn. & TULSA, Okla.–(BUSINESS WIRE)–Oklahoma Heart Institute (OHI), part of Hillcrest HealthCare System and Ardent Health (NYSE: ARDT), is now the only site in Oklahoma and the surrounding region participating in several leading national cardiovascular trials – and recently became the first in the United States to use the next-generation Supira percutaneous left ventricular assist device (pVAD) as part of the SUPPORT II clinical trial. Through this research, OHI is expanding acces
MANHASSET, N.Y.–(BUSINESS WIRE)–With only approximately 10 percent of out-of-hospital cardiac arrest patients surviving, and many facing severe neurological or organ damage, a new study from Northwell Health’s Feinstein Institutes for Medical Research offers hope, revealing that mitochondria transplantation dramatically improves heart recovery and protects organs. Published as a letter to the editor in the American Journal of Respiratory and Critical Care Medicine (AJRCCM), this pivotal large
NEWTON, Mass. and SHEFAYIM, Israel, Aug. 10, 2026 /PRNewswire/ — AQUAPASS, developer of a noninvasive, kidney-independent therapy for fluid overload management in patients experiencing heart failure and chronic or end-stage kidney disease, announced completion of enrollment in its FDA…
Approval opens market access across the UAE through commercial partner UniTech Solutions, bringing rapid, non-invasive coronary artery disease rule-out to point of care OKLAHOMA CITY, Aug. 10, 2026 /PRNewswire/ — Acarix AB (publ) today announced that the CADScor® System has received…
The TFA Cannula incorporates a distal balloon feature designed to allow blood flow to the cannulated limb during cardiopulmonary bypass VANCOUVER, BC, July 30, 2026 /CNW/ — Total Flow Medical, a medical device company developing solutions for extracorporeal circulation, today announced that it has received U.S. Food and Drug Administration (FDA) 510(k) […]
SAN FRANCISCO–(BUSINESS WIRE)– #AI–Cleerly, a leader in advanced cardiac imaging analysis, and Allelica, a precision medicine company specializing in multi-ancestry polygenic risk scores (PRS), today announced a partnership to launch the Cleerly Polygenic Cardiovascular Risk Score Test, powered by Allelica. The test gives physicians a new option to identify and evaluate individuals with an inherited predisposition to coronary plaque. The Cleerly Polygenic Cardiovascular Risk Score Test can be used
Maple Grove, Minnesota, July 29, 2026 – VDyne Inc. (“VDyne”), a privately held medical device company developing an innovative transcatheter tricuspid valve replacement (TTVR) system, today announced that the first patient has been enrolled and treated in the TRIVITA US IDE pivotal study of the TriNovaTM system. The randomized controlled […]
